0 Comentários
0 Compartilhamentos
422 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
The Orphan Drug Premium: Analyzing the Financial Incentives and Pricing Strategies Driving Innovation in the Duchenne Muscular Dystrophy Market.The Duchenne Muscular Dystrophy (DMD) market is fundamentally shaped by the economics of rare diseases, operating under the Orphan Drug framework established by legislation like the U.S. Orphan Drug Act. These incentives—extended market exclusivity, tax credits, and accelerated review—are essential to de-risk the massive R&D investment required for a small patient population....0 Comentários 0 Compartilhamentos 339 Visualizações 0 Anterior
-
Alagille Syndrome Treatment Market Size Projected to Reach USD 158.3 Million by 2032The global Alagille Syndrome Treatment Market focuses on therapies aimed at managing the symptoms and complications of Alagille Syndrome (ALGS), a rare, multi-system genetic disorder caused primarily by mutations in the JAG1 gene. ALGS is characterized by abnormalities in the liver, heart, eyes, skeleton, and kidneys, with the most common and severe manifestation being chronic cholestasis...0 Comentários 0 Compartilhamentos 34 Visualizações 0 Anterior
-
Charcot-Marie-Tooth Disease Market Size Projected to Reach USD 5.96 Billion by 2032The global Charcot-Marie-Tooth Disease Market focuses on the management and development of therapies for CMT, which represents a group of inherited neurological disorders that damage the peripheral nerves, leading to muscle weakness, loss of sensation, and physical impairment, predominantly in the feet, legs, hands, and arms. Currently, the market is characterized primarily by supportive and...0 Comentários 0 Compartilhamentos 29 Visualizações 0 Anterior